1887

Abstract

Hepatitis C virus (HCV) is the major causative agent of hepatocellular carcinoma. However, the precise mechanism underlying the carcinogenesis is yet to be elucidated. It has recently been reported that Syk, a non-receptor protein tyrosine kinase, functions as a potent tumour suppressor in human breast carcinoma. This study first examined the possible effect of HCV infection on expression of Syk . Immunohistochemical analysis revealed that endogenous Syk, which otherwise was expressed diffusely in the cytoplasm of normal hepatocytes, was localized near the cell membrane with a patchy pattern in HCV-infected hepatocytes. The possible interaction between HCV proteins and Syk in human hepatoma-derived Huh-7 cells was then examined. Immunoprecipitation analysis revealed that NS5A interacted strongly with Syk. Deletion-mutation analysis revealed that an N-terminal portion of NS5A (aa 1–175) was involved in the physical interaction with Syk. An kinase assay demonstrated that NS5A inhibited the enzymic activity of Syk and that, in addition to the N-terminal 175 residues, a central portion of NS5A (aa 237–302) was required for inhibition of Syk. Moreover, Syk-mediated phosphorylation of phospholipase C-1 was downregulated by NS5A. An interaction of NS5A with Syk was also detected in Huh-7.5 cells harbouring an HCV RNA replicon or infected with HCV. In conclusion, these results demonstrated that NS5A interacts with Syk resulting in negative regulation of its kinase activity. The results indicate that NS5A may be involved in the carcinogenesis of hepatocytes through the suppression of Syk kinase activities.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83510-0
2008-05-01
2019-11-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/5/1231.html?itemId=/content/journal/jgv/10.1099/vir.0.83510-0&mimeType=html&fmt=ahah

References

  1. Blight, K. J., McKeating, J. A. & Rice, C. M. ( 2002; ). Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol 76, 13001–13014.[CrossRef]
    [Google Scholar]
  2. Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B. & Pawson, T. ( 1995; ). Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378, 303–306.[CrossRef]
    [Google Scholar]
  3. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. ( 1989; ). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359–362.[CrossRef]
    [Google Scholar]
  4. Chung, K. M., Lee, J., Kim, J. E., Song, O. K., Cho, S., Lim, J., Seedorf, M., Hahm, B. & Jang, S. K. ( 2000; ). Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin β3. J Virol 74, 5233–5241.[CrossRef]
    [Google Scholar]
  5. Coopman, P. J., Do, M. T., Barth, M., Bowden, E. T., Hayes, A. J., Basyuk, E., Blancato, J. K., Vezza, P. R., McLeskey, S. W. & other authors ( 2000; ). The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406, 742–747.[CrossRef]
    [Google Scholar]
  6. Corey, S. J., Burkhardt, A. L., Bolen, J. B., Geahlen, R. L., Tkatch, L. S. & Tweardy, D. J. ( 1994; ). Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci U S A 91, 4683–4687.[CrossRef]
    [Google Scholar]
  7. Costello, P. S., Turner, M., Walters, A. E., Cunningham, C. N., Bauer, P. H., Downward, J. & Tybulewicz, V. L. ( 1996; ). Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 13, 2595–2605.
    [Google Scholar]
  8. Deng, L., Nagano-Fujii, M., Tanaka, M., Nomura-Takigawa, Y., Ikeda, M., Kato, N., Sada, K. & Hotta, H. ( 2006; ). NS3 protein of hepatitis C virus associates with the tumor suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J Gen Virol 87, 1703–1713.[CrossRef]
    [Google Scholar]
  9. Doi, H., Apichartpiyakul, C., Ohba, K. I., Mizokami, M. & Hotta, H. ( 1996; ). Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 34, 569–574.
    [Google Scholar]
  10. Evans, M. J., Rice, C. M. & Goff, S. P. ( 2004; ). Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A 101, 13038–13043.[CrossRef]
    [Google Scholar]
  11. Gale, M., Jr, Blakely, C. M., Kwieciszewski, B., Tan, S. L., Dossett, M., Tang, N. M., Korth, M. J., Polyak, S. J., Gretch, D. R. & Katze, M. G. ( 1998; ). Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18, 5208–5218.
    [Google Scholar]
  12. Gao, J., Zoller, K. E., Ginsberg, M. H., Brugge, J. S. & Shattil, S. J. ( 1997; ). Regulation of the pp72syk protein tyrosine kinase by platelet integrin α IIb β 3. EMBO J 16, 6414–6425.[CrossRef]
    [Google Scholar]
  13. Gao, L., Aizaki, H., He, J. W. & Lai, M. M. ( 2004; ). Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol 78, 3480–3488.[CrossRef]
    [Google Scholar]
  14. Ghosh, A. K., Majumder, M., Steele, R., Yaciuk, P., Chrivia, J., Ray, R. & Ray, R. B. ( 2000; ). Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J Biol Chem 275, 7184–7188.[CrossRef]
    [Google Scholar]
  15. Goodman, P. A., Wood, C. M., Vassilev, A., Mao, C. & Uckun, F. M. ( 2001; ). Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia. Oncogene 20, 3969–3978.[CrossRef]
    [Google Scholar]
  16. Hamamoto, I., Nishimura, Y., Okamoto, T., Aizaki, H., Liu, M., Mori, M., Abe, T., Suzuki, T., Lai, M. M. C. & other authors ( 2005; ). Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol 79, 13473–13482.[CrossRef]
    [Google Scholar]
  17. He, Y., Nakao, H., Tan, S. L., Polyak, S. J., Neddermann, P., Vijaysri, S., Jacobs, B. L. & Katze, M. G. ( 2002; ). Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol 76, 9207–9217.[CrossRef]
    [Google Scholar]
  18. Hidajat, R., Nagano-Fujii, M., Deng, L., Tanaka, M., Takigawa, Y., Kitazawa, S. & Hotta, H. ( 2005; ). Hepatitis C virus NS3 protein interacts with ELKS-δ and ELKS-α, members of a novel protein family involved in intracellular transport and secretory pathways. J Gen Virol 86, 2197–2208.[CrossRef]
    [Google Scholar]
  19. Kaneko, T., Tanji, Y., Satoh, S., Hijikata, M., Asabe, S., Kimura, K. & Shimotohno, K. ( 1994; ). Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 205, 320–326.[CrossRef]
    [Google Scholar]
  20. Kurosaki, T., Johnson, S. A., Pao, L., Sada, K., Yamamura, H. & Cambier, J. C. ( 1995; ). Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J Exp Med 182, 1815–1823.[CrossRef]
    [Google Scholar]
  21. Law, C. L., Chandran, K. A., Sidorenko, S. P. & Clark, E. A. ( 1996; ). Phospholipase C-γ1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol 16, 1305–1315.
    [Google Scholar]
  22. Li, J. & Sidell, N. ( 2005; ). Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase. Int J Cancer 117, 14–20.[CrossRef]
    [Google Scholar]
  23. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R. & other authors ( 2005; ). Complete replication of hepatitis C virus in cell culture. Science 309, 623–626.[CrossRef]
    [Google Scholar]
  24. Lohmann, V., Korner, F., Dobierzewska, A. & Bartenschlager, R. ( 2001; ). Mutations in hepatitis C virus RNAs conferring cell culture adaptation. J Virol 75, 1437–1449.[CrossRef]
    [Google Scholar]
  25. Macdonald, A. & Harris, M. ( 2004; ). Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 85, 2485–2502.[CrossRef]
    [Google Scholar]
  26. Macdonald, A., Crowder, K., Street, A., McCormick, C. & Harris, M. ( 2004; ). The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 85, 721–729.[CrossRef]
    [Google Scholar]
  27. Maeda, N., Watanabe, M., Okamoto, S., Kanai, T., Yamada, T., Hata, J., Hozumi, N., Katsume, A., Nuriya, H. & other authors ( 2004; ). Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone. Liver Int 24, 259–267.[CrossRef]
    [Google Scholar]
  28. Majumder, M., Ghosh, A. K., Steele, R., Ray, R. & Ray, R. B. ( 2001; ). Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75, 1401–1407.[CrossRef]
    [Google Scholar]
  29. Mellor, J., Holmes, E. C., Jarvis, L. M., Yap, P. L. & Simmonds, P. ( 1995; ). Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Virol 76, 2493–2507.[CrossRef]
    [Google Scholar]
  30. Miah, S. M., Sada, K., Tuazon, P. T., Ling, J., Maeno, K., Kyo, S., Qu, X., Tohyama, Y., Traugh, J. A. & Yamamura, H. ( 2004; ). Activation of Syk protein tyrosine kinase in response to osmotic stress requires the interaction with p21-activated protein kinase Pak2/γ-PAK. Mol Cell Biol 24, 71–83.[CrossRef]
    [Google Scholar]
  31. Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Wakita, T., Hijikata, M. & Shimotohno, K. ( 2007; ). The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9, 1089–1097.[CrossRef]
    [Google Scholar]
  32. Muramatsu, S., Ishido, S., Fujita, T., Itoh, M. & Hotta, H. ( 1997; ). Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J Virol 71, 4954–4961.
    [Google Scholar]
  33. Okamoto, K., Moriishi, K., Miyamura, T. & Matsuura, Y. ( 2004; ). Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J Virol 78, 6370–6380.[CrossRef]
    [Google Scholar]
  34. Poole, A., Gibbins, J. M., Turner, M., van Vugt, M. J., van de Winkel, J. G., Saito, T., Tybulewicz, V. L. & Watson, S. P. ( 1997; ). The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16, 2333–2341.[CrossRef]
    [Google Scholar]
  35. Qadri, I., Iwahashi, M. & Simon, F. ( 2002; ). Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 1592, 193–204.[CrossRef]
    [Google Scholar]
  36. Reed, K. E. & Rice, C. M. ( 2000; ). Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242, 55–84.
    [Google Scholar]
  37. Robertson, B., Myers, G., Howard, C., Brettin, T., Bukh, J., Gaschen, B., Gojobori, T., Maertens, G., Mizokami, M. & other authors ( 1998; ). Classification, nomenclature, and database development for hepatitis C virus (HCV) and related virus: proposals for standardization. Arch Virol 143, 2493–2503.[CrossRef]
    [Google Scholar]
  38. Sada, K., Zhang, J. & Siraganian, R. P. ( 2000; ). Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J Immunol 164, 338–344.[CrossRef]
    [Google Scholar]
  39. Sada, K., Takano, T., Yanagi, S. & Yamamura, H. ( 2001; ). Structure and function of Syk protein-tyrosine kinase. J Biochem 130, 177–186.[CrossRef]
    [Google Scholar]
  40. Schneider, F. & Kieser, A. ( 2004; ). A novel assay to quantify cell death after transient expression of apoptotic genes in B- and T-lymphocytes. J Immunol Methods 292, 165–174.[CrossRef]
    [Google Scholar]
  41. Shi, S. T., Polyak, S. J., Tu, H., Taylor, D. R., Gretch, D. R. & Lai, M. M. ( 2002; ). Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292, 198–210.[CrossRef]
    [Google Scholar]
  42. Shiue, L., Green, J., Green, O. M., Karas, J. L., Morgenstern, J. P., Ram, M. K., Taylor, M. K., Zoller, M. J., Zydowsky, L. D. & other authors ( 1995; ). Interaction of p72 syk with the γ and β subunits of the high-affinity receptor for immunoglobulin E, FcϵRI. Mol Cell Biol 15, 272–281.
    [Google Scholar]
  43. Simon, M., Vanes, L., Geahlen, R. L. & Tybulewicz, V. L. ( 2005; ). Distinct roles for the linker region tyrosines of Syk in FcϵRI signaling in primary mast cells. J Biol Chem 280, 4510–4517.[CrossRef]
    [Google Scholar]
  44. Song, J., Fujii, M., Wang, F., Itoh, M. & Hotta, H. ( 1999; ). The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J Gen Virol 80, 879–886.
    [Google Scholar]
  45. Street, A., Macdonald, A., Crowder, K. & Harris, M. ( 2004; ). The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade. J Biol Chem 279, 12232–12241.[CrossRef]
    [Google Scholar]
  46. Taguchi, T., Nagano-Fujii, M., Akutsu, M., Kadoya, H., Ohgimoto, S., Ishido, S. & Hotta, H. ( 2004; ). Hepatitis C virus NS5A protein interacts with 2′,5′-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J Gen Virol 85, 959–969.[CrossRef]
    [Google Scholar]
  47. Takigawa, Y., Nagano-Fujii, M., Deng, L., Hidajat, R., Tanaka, M., Mizuta, H. & Hotta, H. ( 2004; ). Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Microbiol Immunol 48, 591–598.[CrossRef]
    [Google Scholar]
  48. Tan, S. L., Nakao, H., He, Y., Vijaysri, S., Neddermann, P., Jacobs, B. L., Mayer, B. J. & Katze, M. G. ( 1999; ). NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96, 5533–5538.[CrossRef]
    [Google Scholar]
  49. Taniguchi, T., Kobayashi, T., Kondo, J., Takahashi, K., Nakamura, H., Suzuki, J., Nagai, K., Yamada, T., Nakamura, S. & Yamamura, H. ( 1991; ). Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem 266, 15790–15796.
    [Google Scholar]
  50. Tellinghuisen, T. L., Marcotrigiano, J. & Rice, C. M. ( 2005; ). Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435, 374–379.[CrossRef]
    [Google Scholar]
  51. Tsuchida, S., Yanagi, S., Inatome, R., Ding, J., Hermann, P., Tsujimura, T., Matsui, T. & Yamamura, H. ( 2000; ). Purification of a 72-kDa protein-tyrosine kinase from rat liver and its identification as Syk: involvement of Syk in signaling events of hepatocytes. J Biochem 127, 321–327.[CrossRef]
    [Google Scholar]
  52. Turner, M., Mee, P. J., Costello, P. S., Williams, O., Price, A. A., Duddy, L. P., Furlong, M. T., Geahlen, R. L. & Tybulewicz, V. L. ( 1995; ). Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298–302.[CrossRef]
    [Google Scholar]
  53. Turner, M., Schweighoffer, E., Colucci, F., Di Santo, J. P. & Tybulewicz, V. L. ( 2000; ). Tyrosine kinase SYK: essential functions for immunoreceptor signalling. Immunol Today 21, 148–154.[CrossRef]
    [Google Scholar]
  54. Ulanova, M., Puttagunta, L., Marcet-Palacios, M., Duszyk, M., Steinhoff, U., Duta, F., Kim, M. K., Indik, Z. K., Schreiber, A. D. & Befus, A. D. ( 2005; ). Syk tyrosine kinase participates in β1-integrin signaling and inflammatory responses in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 288, L497–L507.[CrossRef]
    [Google Scholar]
  55. Wang, S., Ding, Y. B., Chen, G. Y., Xia, J. G. & Wu, Z. Y. ( 2004; ). Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol 10, 1815–1818.
    [Google Scholar]
  56. Weiss, A. & Littman, D. R. ( 1994; ). Signal transduction by lymphocyte antigen receptors. Cell 76, 263–274.[CrossRef]
    [Google Scholar]
  57. Wienands, J., Larbolette, O. & Reth, M. ( 1996; ). Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc Natl Acad Sci U S A 93, 7865–7870.[CrossRef]
    [Google Scholar]
  58. Yamada, T., Fujieda, S., Yanagi, S., Yamamura, H., Inatome, R., Sunaga, H. & Saito, H. ( 2001; ). Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production. J Immunol 166, 538–543.[CrossRef]
    [Google Scholar]
  59. Yanagi, S., Kurosaki, T. & Yamamura, H. ( 1995; ). The structure and function of nonreceptor tyrosine kinase p72SYK expressed in hematopoietic cells. Cell Signal 7, 185–193.[CrossRef]
    [Google Scholar]
  60. Yanagi, S., Inatome, R., Ding, J., Kitaguchi, H., Tybulewicz, V. L. & Yamamura, H. ( 2001; ). Syk expression in endothelial cells and their morphologic defects in embryonic Syk-deficient mice. Blood 98, 2869–2871.[CrossRef]
    [Google Scholar]
  61. Yasui, K., Wakita, T., Tsukiyama-Kohara, K., Funahashi, S. I., Ichikawa, M., Kajita, T., Moradpour, D., Wands, J. R. & Kohara, M. ( 1998; ). The native form and maturation process of hepatitis C virus core protein. J Virol 72, 6048–6055.
    [Google Scholar]
  62. Yuan, Y., Mendez, R., Sahin, A. & Dai, J. L. ( 2001; ). Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 61, 5558–5561.
    [Google Scholar]
  63. Yuan, Y., Wang, J., Li, M., Yan, Z., Zhang, C. & Dai, J. L. ( 2006; ). Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res 12, 6687–6695.[CrossRef]
    [Google Scholar]
  64. Zech, B., Kurtenbach, A., Krieger, N., Strand, D., Blencke, S., Morbitzer, M., Salassidis, K., Cotten, M., Wissing, J. & other authors ( 2003; ). Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein. J Gen Virol 84, 555–560.[CrossRef]
    [Google Scholar]
  65. Zhang, J., Berenstein, E. & Siraganian, R. P. ( 2002; ). Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc-ϵRI signaling in mast cells. Mol Cell Biol 22, 8144–8154.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83510-0
Loading
/content/journal/jgv/10.1099/vir.0.83510-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error